Cargando…
Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy
Previous literature regarding coronavirus disease 2019 outlined a presence of organ dysfunction including acute respiratory distress syndrome and acute kidney injury that are linked to mortality. Several patients require extracorporeal therapy. This review aims to gather available published resource...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531758/ https://www.ncbi.nlm.nih.gov/pubmed/33063039 http://dx.doi.org/10.1097/CCE.0000000000000242 |
_version_ | 1783589792814989312 |
---|---|
author | Chaijamorn, Weerachai Rungkitwattanakul, Dhakrit Nuchtavorn, Nantana Charoensareerat, Taniya Pattharachayakul, Sutthiporn Sirikun, Wiriyaporn Srisawat, Nattachai |
author_facet | Chaijamorn, Weerachai Rungkitwattanakul, Dhakrit Nuchtavorn, Nantana Charoensareerat, Taniya Pattharachayakul, Sutthiporn Sirikun, Wiriyaporn Srisawat, Nattachai |
author_sort | Chaijamorn, Weerachai |
collection | PubMed |
description | Previous literature regarding coronavirus disease 2019 outlined a presence of organ dysfunction including acute respiratory distress syndrome and acute kidney injury that are linked to mortality. Several patients require extracorporeal therapy. This review aims to gather available published resources including physicochemical and pharmacokinetic properties and suggests antiviral drug dosing adaptation for coronavirus disease 2019–infected critically ill patients receiving extracorporeal therapy. A literature search was performed using PubMed, clinical trial registries, and bibliographic review of textbooks and review articles. Unfortunately, no standard of pharmacologic management and recommendations of drug dosing for coronavirus disease 2019 infection for critically ill patients receiving extracorporeal therapy exist due to the limited data on pharmacokinetic and clinical studies. All available extracted data were analyzed to suggest the appropriate drug dosing adjustment. Antiviral drug dosing adjustments for critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy are presented in this review. Considering pathophysiologic changes, drug properties, and extracorporeal modalities, applying our suggestions is recommended. |
format | Online Article Text |
id | pubmed-7531758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-75317582020-10-14 Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy Chaijamorn, Weerachai Rungkitwattanakul, Dhakrit Nuchtavorn, Nantana Charoensareerat, Taniya Pattharachayakul, Sutthiporn Sirikun, Wiriyaporn Srisawat, Nattachai Crit Care Explor Commentary Previous literature regarding coronavirus disease 2019 outlined a presence of organ dysfunction including acute respiratory distress syndrome and acute kidney injury that are linked to mortality. Several patients require extracorporeal therapy. This review aims to gather available published resources including physicochemical and pharmacokinetic properties and suggests antiviral drug dosing adaptation for coronavirus disease 2019–infected critically ill patients receiving extracorporeal therapy. A literature search was performed using PubMed, clinical trial registries, and bibliographic review of textbooks and review articles. Unfortunately, no standard of pharmacologic management and recommendations of drug dosing for coronavirus disease 2019 infection for critically ill patients receiving extracorporeal therapy exist due to the limited data on pharmacokinetic and clinical studies. All available extracted data were analyzed to suggest the appropriate drug dosing adjustment. Antiviral drug dosing adjustments for critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy are presented in this review. Considering pathophysiologic changes, drug properties, and extracorporeal modalities, applying our suggestions is recommended. Lippincott Williams & Wilkins 2020-10-01 /pmc/articles/PMC7531758/ /pubmed/33063039 http://dx.doi.org/10.1097/CCE.0000000000000242 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Commentary Chaijamorn, Weerachai Rungkitwattanakul, Dhakrit Nuchtavorn, Nantana Charoensareerat, Taniya Pattharachayakul, Sutthiporn Sirikun, Wiriyaporn Srisawat, Nattachai Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy |
title | Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy |
title_full | Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy |
title_fullStr | Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy |
title_full_unstemmed | Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy |
title_short | Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy |
title_sort | antiviral dosing modification for coronavirus disease 2019–infected patients receiving extracorporeal therapy |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531758/ https://www.ncbi.nlm.nih.gov/pubmed/33063039 http://dx.doi.org/10.1097/CCE.0000000000000242 |
work_keys_str_mv | AT chaijamornweerachai antiviraldosingmodificationforcoronavirusdisease2019infectedpatientsreceivingextracorporealtherapy AT rungkitwattanakuldhakrit antiviraldosingmodificationforcoronavirusdisease2019infectedpatientsreceivingextracorporealtherapy AT nuchtavornnantana antiviraldosingmodificationforcoronavirusdisease2019infectedpatientsreceivingextracorporealtherapy AT charoensareerattaniya antiviraldosingmodificationforcoronavirusdisease2019infectedpatientsreceivingextracorporealtherapy AT pattharachayakulsutthiporn antiviraldosingmodificationforcoronavirusdisease2019infectedpatientsreceivingextracorporealtherapy AT sirikunwiriyaporn antiviraldosingmodificationforcoronavirusdisease2019infectedpatientsreceivingextracorporealtherapy AT srisawatnattachai antiviraldosingmodificationforcoronavirusdisease2019infectedpatientsreceivingextracorporealtherapy |